|
ZNF182 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53974619113251E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.49279999659558E-08 |
| Normal-vs-Stage2 |
4.87670000004492E-06 |
| Normal-vs-Stage3 |
1.49710022157024E-10 |
| Normal-vs-Stage4 |
5.41020000022208E-07 |
| Stage1-vs-Stage2 |
9.147400E-01 |
| Stage1-vs-Stage3 |
4.783700E-02 |
| Stage1-vs-Stage4 |
3.887800E-01 |
| Stage2-vs-Stage3 |
2.377600E-01 |
| Stage2-vs-Stage4 |
5.810000E-01 |
| Stage3-vs-Stage4 |
5.813400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52999835023593E-11 |
| Normal-vs-AfricanAmerican |
2.976000E-04 |
| Normal-vs-Asian |
1.5278199999913E-05 |
| Caucasian-vs-AfricanAmerican |
9.488000E-01 |
| Caucasian-vs-Asian |
5.312800E-01 |
| AfricanAmerican-vs-Asian |
7.162400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.30710000001422E-06 |
| Normal-vs-Female |
2.73129996397614E-09 |
| Male-vs-Female |
7.583600E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.33669999957675E-07 |
| Normal-vs-Age(41-60Yrs) |
1.12679976460583E-10 |
| Normal-vs-Age(61-80Yrs) |
1.86759999687425E-08 |
| Normal-vs-Age(81-100Yrs) |
1.984300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.567000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.080600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.533200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.290600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.630000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.170200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.1220000000064E-05 |
| Classical-VS-Follicular |
4.637200E-01 |
| Classical-VS-Other |
4.556000E-01 |
| Classical-VS-Normal |
4.84139999978872E-07 |
| Tall-VS-Follicular |
3.324300E-03 |
| Tall-VS-Other |
7.317500E-03 |
| Tall-VS-Normal |
2.50429676995623E-11 |
| Follicular-VS-Other |
3.945200E-01 |
| Follicular-VS-Normal |
2.52959999946789E-07 |
| Other-VS-Normal |
1.331750E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.64539501415584E-11 |
| Normal-vs-N1 |
3.50829999999913E-05 |
| N0-vs-N1 |
6.059800E-01 |
|
|
